Previous 10 | Next 10 |
home / stock / hlukf / hlukf news
H. Lundbeck A/S press release (OTC:HLUKF): FY GAAP EPS of DKK6.63. Revenue of DKK16.3B (-7.8% Y/Y). For further details see: H. Lundbeck A/S GAAP EPS of DKK6.63, revenue of DKK16.3B
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2021 Q3 earnings call. For further details see: H. Lundbeck A/S 2021 Q3 - Results - Earnings Call Presentation
H. Lundbeck A/S (HLUKF) Q3 2021 Earnings Conference Call November 10, 2021 07:00 AM ET Company Participants Deborah Dunsire - President & CEO Johan Luthman - EVP of Research & Development Anders Götzsche - Executive VP & CFO Jacob Tolstrup - EVP of Commercial Operations Peter...
H. Lundbeck A/S (OTC:HLUKF): Q3 Non-GAAP EPS of DKK2.78; GAAP EPS of DKK1.62. Revenue of DKK4.01B (-10.1% Y/Y). Press Release For further details see: H. Lundbeck A/S reports Q3 results
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2021 Q2 earnings call. For further details see: H. Lundbeck A/S 2021 Q2 - Results - Earnings Call Presentation
H. Lundbeck A/S (HLUKF) Q2 2021 Earnings Conference Call August 18, 2021 07:00 ET Company Participants Deborah Dunsire - President and Chief Executive Officer Anders Götzsche - Executive Vice President and Chief Financial Officer Johan Luthman - Executive Vice President, Research & D...
With the interim analysis of the Rexulti Alzheimer's agitation study leading to study continuation, Lundbeck's cupboard of near-term catalysts is looking pretty bare. A strong efficacy signal in the Phase II Rexulti study in borderline personality disorder or strong acceleration in Vy...
BeiGene of Beijing has been approved to stage a $3 billion IPO on the Shanghai Star Stock Exchange. Zentalis Pharma, a US-China biopharma, closed a $150 million secondary offering to advance its small molecule cancer portfolio. Shanghai I-Mab announced it has achieved several clin...
H Lundbeck A/S (HLUKF) Q1 2021 Earnings Conference Call May 11, 2021, 07:00 ET Company Participants Deborah Dunsire - President & CEO Anders Götzsche - EVP & CFO Johan Luthman - EVP, Research & Development Peter Anastasiou - EVP, North America Jacob Tolstrup - EVP, Commercial...
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2021 Q1 earnings call. For further details see: H. Lundbeck A/S 2021 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
H Lundbeck A/S Company Name:
HLUKF Stock Symbol:
OTCMKTS Market:
COPENHAGEN, Denmark , Aug. 31, 2020 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced headline results from the parallel group, double-blind, randomized, placebo-controlled RELIEF study [i] that assessed the efficacy and tolerability of Vyepti when initiated during a migrain...
Health Canada Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder Canada NewsWire MONTREAL, Feb. 22, 2019 MONTREAL , Feb. 22, 2019 /CNW Telbec/ - Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Can...